Allergies

OMNARIS^® (ciclesonide) Nasal Spray

Over 40 million Americans suffer from allergic rhinitis. OMNARIS^® (ciclesonide) Nasal Spray is a once-a-day medication that combats allergic inflammation, a major cause of both seasonal and perennial (year-round) nasal allergies. It's an effective medication for reducing nasal symptoms including: the congestion, runny nose, itchy nose, and sneezing, in adults and children 6 years and up who suffer from seasonal allergies like hay fever. OMNARIS also brings safe, all-day-long relief to adults and adolescents 12 and older who have year-round allergies to irritants like pet dander or dust.  

You'll find more information about OMNARIS Nasal Spray at www.omnaris.com.

Important Safety Information:
Ciclesonide nasal spray was shown to have a favorable safety profile. The most frequently reported adverse events seen with ciclesonide nasal spray were headache, epistaxis, nasopharyngitis, ear pain, and pharyngolaryngeal pain. The replacement of a systemic corticosteroid with a topical corticosteroid can be accompanied by signs of adrenal insufficiency. Intranasal corticosteroids may cause a reduction in growth velocity when administered to pediatric patients.

Ciclesonide Nasal Aerosol (HFA)

Ciclesonide Nasal Aerosol (HFA), currently in development, has the potential to be the first FDA-approved HFA nasal aerosol for the treatment of nasal allergies, also referred to as allergic rhinitis. Ciclesonide Nasal Aerosol (HFA) has been evaluated in adult and adolescent patients 12 years of age and older with Seasonal Allergic Rhinitis (SAR, better known as "hay fever") and Perennial Allergic Rhinitis (PAR, year-round). The clinical program has evaluated Ciclesonide Nasal Aerosol (HFA) for both ocular symptoms and nasal symptoms that included congestion, runny nose, sneezing, itchy nose. Ciclesonide Nasal Aerosol (HFA) is delivered as a fine mist.